top of page

Test and Treat Patients Faster. Generate Immediate, Accurate Results For Real-Time Diagnosis and Monitoring of Diabetes.

OBM rapid A1c_Professional.jpg

OBM rapid A1c Test

OBM rapid A1c is a portable A1c testing device requiring only one blood sample drop. The palm-sized device is easy to use, with no prior training or experience necessary.

​

Featuring microfluidic technology, OBM rapid A1c is tolerant of possible inconsistencies in sampling volume. Test results are not affected by hemoglobin variants, unlike other POC tests.

The first-of-its-kind approach enables accurate assessment every time, regardless of who performs or takes the test.

A1c testing for healthcare providers
Diabetes management solutions

Did you know?

In addition to its portability and high accuracy, OBM rapid A1c meter has an infinite shelf life, and its cartridges have a 2-year long life. Units can be purchased in bulk for long-term use.

​

The meter can also be reused without any required maintenance or calibration, perfect for Primary Care Physicians, Endocrinologists, and Cardiologists needing an all-in-one solution. 

 

The system is reusable, enabling physicians to quickly test multiple patients, more rapidly across healthcare settings.

OBM rapid A1c Requires

No Operator Calibration
No Maintenance
No Refrigeration

Benefits of OBM rapid A1c

Device:

  • Portable, pocket-sized device

  • Zero maintenance

  • Easy to use

  • Results in only 5 minutes

  • No hemoglobin variant interference

  • Tolerance to varying sampling volume

​

Cartridge:

  • 24-month-long shelf life

  • No refrigeration

​

​

A1c monitoring tools
Diabetes care technology

Product Specifications

  • Device Weight: 0.2 lbs

  • Device Dimensions: 2.7 in x 3.8 in x 1.1 in

  • Sample Volume: 0.003 mL (3µl)

  • Number of Cartridges Per Box: 100

 

5-minute test for in-clinic or on-the-go use.

Order a trial kit to discover a new way of testing A1c.

Competitive Comparison: A1c Devices for Professional Usage

*Based on recent findings from our clinical trials, we anticipate that the CV accuracy for OBM rapid A1c will be <2%.

bottom of page